Safety and Efficacy of Varying Regimens of CANDIN for Treatment of Common Warts (Verruca Vulgaris)
Public ClinicalTrials.gov record NCT02393417. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase IIa, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Varying Regimens of CANDIN for Treatment of Common Warts (Verruca Vulgaris)
Study identification
- NCT ID
- NCT02393417
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Nielsen BioSciences, Inc.
- Industry
- Enrollment
- 243 participants
Conditions and interventions
Conditions
Interventions
- CANDIN Biological
- Placebo Other
Biological · Other
Eligibility (public fields only)
- Age range
- 18 Years to 65 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 28, 2015
- Primary completion
- Dec 31, 2017
- Completion
- Feb 28, 2018
- Last update posted
- Jun 3, 2019
2015 – 2018
United States locations
- U.S. sites
- 15
- U.S. states
- 10
- U.S. cities
- 14
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Johnson Dermatology | Fort Smith | Arkansas | 72916 | — |
| Northwest Arkansas Clinical Trials Center PLLC | Rogers | Arkansas | 72758 | — |
| California Dermatology and Clinical Research Institute | Encinitas | California | 92024 | — |
| Silverberg MD Inc. | Newport Beach | California | 92660 | — |
| Metro Boston Clinical Partners, LLC | Needham | Massachusetts | 02492 | — |
| BayState Clinical Trials | Watertown | Massachusetts | 02472 | — |
| Hamzavi Dermatology Clinical Trials | Fort Gratiot | Michigan | 48059 | — |
| Minnesota Clinical Study Center | Fridley | Minnesota | 55432 | — |
| Dermatology Consulting Services | High Point | North Carolina | 27262 | — |
| Oregon Medical Research Center | Portland | Oregon | 97223 | — |
| Austin Institute for Clinical Research Inc. | Austin | Texas | 78660 | — |
| DermResearch Inc. | Austin | Texas | 78759 | — |
| Texas Dermatology and Laser Specialists | San Antonio | Texas | 78218 | — |
| Dermatology Research Center, Inc. | Salt Lake City | Utah | 84117 | — |
| The Education and Research Foundation, Inc. | Lynchburg | Virginia | 24501 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02393417, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 3, 2019 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02393417 live on ClinicalTrials.gov.